PPE Now A Counterfeit Market
Industry News

Pharmaceuticals Industry News

Documenting timely news on recalls, counterfeiting, and supply chain compromises across industries.

PharmaceuticalsJune 10, 2020

PPE Now A Counterfeit Market

As with other goods sold in the marketplace, PPE (personal protective equipment) is not immune to the counterfeit market. In a time when federal limitations were put in place to provide for availability and stability of pricing, there were still some companies that took advantage of the pandemic panic.  A new lawsuit for N95 masks sold through Amazon is the latest to come to light.

Learn More

PharmaceuticalsApril 3, 2020

Zantac Removed from Market by FDA

Popular over the counter medication Zantac, along with many others, is being removed from store shelves after its link to cancer. An ingredient in many antacid products called Ranitidine has been shown to contain NDMA, a cancer causing carcinogen. . Due to the Coronavirus the FDA recommends following disposal guidelines provided with the medication.

Learn More

PharmaceuticalsMarch 27, 2020

Public Health Crisis Opens Door for Counterfeiters

As citizens are asked to stay home the rise of online platforms has seen unprecedented traffic and movement, leading to vulnerable shoppers that fall victim to counterfeits. Interpol released a statement warning that people are producing counterfeit COVID19 products including a “Corona Spray” and other COVID branded items. With a public health crisis counterfeiters are known to create false drugs, fake masks, and other medical equipment and attempt to sneak them into a legitimate supply chain. The United States along with other international organizations urge people to be especially alert in these times of hardship and should verify producers before purchasing supplies from e-Commerce sites.

Learn More

PharmaceuticalsJanuary 2, 2020

Infant Ibuprofen Recall

Infant Ibuprofen has recently been recalled by Tris Pharma for reportedly containing a higher concentration of medication than labeled. Tris claims affected pills contain about 10% more concentrated ibuprofen. While the possibility of illness or death is remote the company did not wish to take any chances and advised consumers to either return or discard the product.

Learn More

PharmaceuticalsOctober 21, 2019

33,000 Bottles of Baby Powder Recalled

Johnson & Johnson amid allegations of asbestos tainted talc is launching a recall for Johnson’s Baby Powder, a common household item, as well as an investigation into potentially counterfeit products. FDA testing has tested positive for traces of asbestos in online-bought products. 

Learn More

PharmaceuticalsJuly 21, 2019

Potential Fake Supplements Sold on Amazon

Third-party sellers who market all kinds of fake products have been a constant pain point to major online retailer Amazon. Although there have been several initiatives to detect and minimize counterfeiters listing goods in their marketplace, brands typically need to elect to participate. Most recently, a popular nutritional supplement was identified as potentially counterfeit. Amazon contacted customers who had purchased the item disclosing the probably information and added a full refund would be provided.  While Amazon is both a retailer and a third-party marketplace, the line between the two parts of it’s business can be a bit of a grey area. 

Learn More

PharmaceuticalsJune 21, 2019

FDA Joining Supply Chain Pilot Project

On the verge of the Drug Supply Chain Security Act (DSCSA) coming into effect in 2023, the FDA announces participation in a pilot project to improve drug supply chain and tractability in the United States. This pilot project encompasses more than 20 companies in the health and pharmaceutical industries to explore and evaluate methods of enhancing safety and identify and trace prescription drugs distributed.  

Learn More

PharmaceuticalsMay 24, 2019

Voluntary Recall of Veterinary Injectable Drug Products Due To Sterilization Compromises

Norbrook Laboratories Limited announced the voluntary recall of 34 lots of its veterinary injectable drug products distributed across the United States. After distribution, the recalled products were discovered to have been manufactured on an aseptic line that did not pass process simulation tests, proving the importance of real-time production line monitoring to alert manufacturers in the event of compromise.

Learn More

PharmaceuticalsApril 29, 2019

Back Heating Pads Recalled Nationwide Due to Potential Risk of Skin Injury

Pfizer Consumer Healthcare issued a nationwide recall of its ThermaCare® Back Pain Therapy HeatWraps due to the potential risk that certain cells within the wrap operate at an increased temperature, which poses the risk of burns, blisters, and irritation to applied areas. A total of 17 case sub lots distributed from June 2017 through March 2018 were impacted by the recall.

Learn More